Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
6
×
life sciences
national blog main
national top stories
roche
6
×
boston blog main
boston top stories
clinical trials
san francisco top stories
deals
san francisco blog main
boston
investing
national
new york top stories
amgen
biogen
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
detroit blog main
detroit top stories
eli lilly
europe top stories
genentech
glaxosmithkline
indiana blog main
indiana top stories
merck
new york blog main
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
rna interference
san diego blog main
san diego top stories
seattle blog main
What
drug
roche
cancer
fda
intended
medicines
patients
team
alliance
analytics
annual
approval
approved
ash
atrophy
barcelona
bio
biofourmis
blueprint
bristol
buy
calls
candidate
caught
causing
changing
clinical
color
conference
crispr
currently
daily
data
days
december's
devices
dicerna
digital
disease
employs
Language
unset
6
×
Current search:
roche
×
fda
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More